Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(-)-trans-delta-9-Tetrahydrocannabinol1件: Dronabinol1件: D00306 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13
2(IM) AVONEX®1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
3(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide----1件: 13
40,5 mg Fingolimod1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
50.25 mg RPC1063----3件: 13, 96, 97
60.25mg RPC1063----2件: 13, 97
70.5 mg RPC1063----2件: 13, 97
80.5mg RPC1063----1件: 13
9032166011----1件: 13
10033283045----1件: 13
11034091165----1件: 13
12035418060----1件: 13
131 - Andrographis paniculata p/st extract----1件: 13
141 mg RPC1063----2件: 13, 97
151% Steroid Cream----1件: 13
161-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone----1件: 13
171.0mg RPC1063----1件: 13
1810 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
1910000IU vitamin D1件: Vitamin D---1件: 13
2011C-ACETATE2件: Acetate,
Acetic acid C-11		---4件: 6, 13, 86, 88
2111C-BMS-986196----1件: 13
2211C-MCI----1件: 13
2311C-PBR28----2件: 6, 13
2411C-PiB----2件: 6, 13
2511C-PS13----2件: 6, 13
2611C]-PK-11195----1件: 13
2711C]flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13
2813-PCV Booster----1件: 13
2913-valent pneumococcal conjugate vaccine (13-PCV)----1件: 13
301393641-34-3----1件: 13
3114C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration----3件: 13, 96, 97
3215 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
3318F-DPA-714 and 18F-FDG1件: Fludeoxyglucose (18F)---1件: 13
3418F-FDG1件: Fludeoxyglucose (18F)---8件: 5, 6, 7, 13, 84, 85, 127, 300
3518F-PM-PBB3----1件: 13
3618F]DPA-714----2件: 13, 127
3719 nor vitamin d1件: Vitamin D---1件: 13
382 - Excipients----1件: 13
392-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester----1件: 13
402-CdA1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
412-CdA, 2-chloro-2'-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
422-CdA, 2-chloro-2'-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
432-CdA, 2-chloro-2?-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
442-CdA, 2-chloro-2?-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
452-CdA, 2-chloro-2’-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
462-CdA, 2-chloro-2’-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
472-chloro-2'-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
482-chloro-2'-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
492-chloro-2'-deoxyadenosine (2-CdA)1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
502-chloro-2'-deoxyadenosine, 2CdA----1件: 13
512-chloro-2?-deoxy-beta-D-adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
522-chloro-2?-deoxy-ß-D-adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
532-chloro-2’-deoxy-beta-D-adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
542-chloro-2’-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
552-chloro-2’-deoxy-ß-D-adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
562-chloro-2’-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
572-chloro-2’-deoxyadenosine (2-CdA)1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
5820 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
5920 mg GA----1件: 13
6020 mg MitoQ----1件: 13
61200106 or EMD 28162----1件: 13
6220mg/0.5ml GA----1件: 13
6320mg/0.5ml glatiramer acetate2件: Acetate,
Glatiramer		---1件: 13
6423-PPV----1件: 13
6523-valent pneumococcal polysaccharide vaccine----3件: 13, 46, 53
6623-valent pneumococcal polysaccharide vaccine (23-PPV)----1件: 13
6725(OH)D3----1件: 13
6825OH-Vitamin D1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13
692B3-201----1件: 13
703 mg Melatonin1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13
713,4-DIAMINOPYRIDINE----2件: 12, 13
724-Aminopyridine1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 13
734-AP1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
744.5 mg Naltrexone1件: Naltrexone1件: D05113 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
7540 mg GA----2件: 2, 13
7640 mg glatiramer acetate2件: Acetate,
Glatiramer		---2件: 2, 13
7740 mg Glatiramer acetato1件: Glatiramer---1件: 13
7840mg of MitoQ----1件: 13
795 mg Melatonin1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13
805000IU vitamin D1件: Vitamin D---1件: 13
8152069.00.01----1件: 13
829060X----2件: 13, 149
8395% Pure ECGC capsules 200mg----1件: 13
84[123I]CLINDE----2件: 6, 13
85[18F] PBR06----2件: 6, 13
86[18F]-FEPPA----2件: 6, 13
87[18F]Florbetapir PET imaging----1件: 13
88[C-11]Methylreboxetine----1件: 13
89[C-11]PBR28----1件: 13
90[C11]PK-1195 PET scan----1件: 13
91[F-18]PBR06----1件: 13
92[F-18]SDM-8----1件: 13
93[Zr-89]Oxine-labeled leukocytes PET/MRI1件: Oxyquinoline1件: D05321 --1件: 13
94A4I Antagonist----1件: 13
95AB1010----6件: 2, 5, 6, 13, 46, 96
96Abatacept1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300
97Abobotulinumtoxin A----1件: 13
98ABR-215062----1件: 13
99ABR-215062 sodium salt----2件: 13, 96
100ABT-555----1件: 13
101ABT-874/Human monoclonal antibody against IL-12----1件: 13
102ABX-14311件: ABX-1431---1件: 13
103ABX-1431 HCl1件: ABX-1431---1件: 13
104Acetaminophen1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬13件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337
105Acetaminophen Tablet 650mg1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
106Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
107Acetazolamide1件: Acetazolamide1件: D00218 13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬		7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬6件: 13, 90, 115, 155, 225, 230
108Acetylcysteine1件: Acetylcysteine1件: D00221 --21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
109ACETYLSALICYLIC ACID1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 51, 210
110Acetylsalicylic acid at 1st visit,1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
111Aciclovir1件: Acyclovir1件: D00222 --3件: 13, 28, 60
112Aclasta----3件: 13, 271, 274
113Aclasta 5 mg Infusionslösung1件: Zoledronic acid2件: D01968 ,
D08689 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13
114Aclasta 5mg solution for infusion----1件: 13
115ACT----1件: 13
116ACT-1----1件: 13
117ACT-128800----1件: 13
118ACT-128800 Dose 1----1件: 13
119ACT-128800 Dose 2----1件: 13
120ACT-128800 Dose 3----1件: 13
121ACTH1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 13, 66, 145, 222
122Acthar1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222
123Acthar Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 13, 46, 49, 50, 84, 222
124ACTHAR Gel (ACTH)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13
125Active Comparator receiving Extavia®1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
126Active Control----1件: 13
127ACTOS (Pioglitazone)1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 13
128Acyclovir1件: Acyclovir1件: D00222 --2件: 13, 28
129Ad26.COV2.S----7件: 13, 35, 46, 49, 50, 51, 107
130Adderall XR----1件: 13
131Adderall XR 10 mg----1件: 13
132Adderall XR 5mg----1件: 13
133Adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 13, 58, 65
134Adrenocorticotropic Hormone1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 13, 50, 84
135Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13
136ADS-5102----2件: 6, 13
137ADS-5102, 137 mg----1件: 13
138ADS-5102, 274 mg----1件: 13
139AERT, (R)-Baclofen1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
140AGEE cream----1件: 13
141AHSC----1件: 13
142AIMSPRO----2件: 13, 51
143AIN----1件: 13
144AIN457----8件: 13, 37, 41, 46, 56, 96, 107, 271
145AL----11件: 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127
146Alanine1件: Alanine1件: D00012 --4件: 6, 13, 298, 299
147Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14
148Albuterol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 12, 13, 86, 89, 113, 256, 299
149ALEMTUZUMAB1件: Alemtuzumab1件: D02802 1件: CD52 💬-17件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284
150Alemtuzumab (GZ402673)1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
151Alemtuzumab 12 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
152Alemtuzumab 24 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
153Alemtuzumab GZ4026731件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
154Alemtuzumab immunotherapy1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
155Alemtuzumab Injection1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
156Alemtuzumab Injection [Lemtrada]1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
157Alfuzosin1件: Alfuzosin1件: D07124 1件: ADRA1A 💬7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 13
158ALKS 8700----1件: 13
159ALKS 8700 Delayed Release (DR)1件: Manganese citrate---1件: 13
160ALKS 8700 Delayed Release (DR) Capsule1件: Manganese citrate---1件: 13
161All patients in the study will be treated with ocrelizumab1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
162Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells----1件: 13
163Allogeneic umbilical cord mesenchymal stem cells----1件: 13
164AlloRx----8件: 2, 6, 13, 46, 51, 85, 90, 226
165Alpha Lipoic Acid1件: Lipoic acid---1件: 13
166ALPHA-LIPOIC ACID1件: Lipoic acid---2件: 2, 13
167Alpha1-antitrypsin----1件: 13
168ALTRI FARMACI DEL SISTEMA NERVOSO----1件: 13
169ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109
170AMANTADINE1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬4件: 6, 8, 13, 127
171AMANTADINE HYDROCHLORIDE1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 6, 13
172Amantadine Level1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13
173American Ginseng2件: Ginseng,
Panax quinquefolius whole		1件: D06772 --1件: 13
174American ginseng extract HT-10012件: Ginseng,
Panax quinquefolius whole		1件: D06772 --1件: 13
175Amiloride1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬4件: 13, 67, 225, 299
176Amiloride Hydrochloride1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13
177AMILORIDE HYDROCHLORIDE, 2 H2O1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13
178Amilostad----1件: 13
179Amilostad HCT----1件: 13
180Amilostad HCT tablets----1件: 13
181Ampyra1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 6, 13
182Amyvid1件: Florbetapir (18F)---2件: 13, 127
183Amyvid radiopharmaceutical1件: Florbetapir (18F)---1件: 13
184AN100226----2件: 13, 96
185AN100226, BG00002----1件: 13
186Anakinra1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬16件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299
187AndroGel 1 % Topical Gel----1件: 13
188Androgel 10 grams of gel containing 100 mg of testosterone1件: Testosterone1件: D00075 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13
189Andrographolides----1件: 13
190Anesthetic Topical Adhesive Synera----1件: 13
191ANK-700----1件: 13
192Anti LP40 antibody, subclass IgG4 LA294----2件: 13, 46
193Anti-CD25 Humanized Monoclonal Antibody----1件: 13
194Anti-CD52 monoclonal antibody----1件: 13
195Anti-IL-12----2件: 13, 96
196Anti-Mullerian hormone (AMH) level----1件: 13
197Anti-Thymocyte Globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285
198Anticholinergic medication----1件: 13
199Anticuerpo monoclonal anti-LINGO-1 humano----1件: 13
200Antihistamine----2件: 13, 46
201Antimycotic----1件: 13
202Antithymocyte----1件: 13
203ANTITHYMOCYTE IMMUNOGLOBULIN1件: Antithymocyte immunoglobulin (rabbit)---2件: 13, 96
204Antithymocyte immunoglobulin (rabbit)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---2件: 13, 96
205Anxiety/depression and work and activities----1件: 13
206AP----4件: 2, 6, 13, 299
207Apitox - pure honeybee toxin----1件: 13
208Arbaclofen1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬2件: 13, 206
209Arbaclofen ER Tablets1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
210Arbaclofen Extended Release Tablets1件: Arbaclofen1件: D09791 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
211Arbaclofen Placarbil2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
212Arbaclofen placarbil 15 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
213Arbaclofen placarbil 30 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
214Arbaclofen placarbil 45 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: D08861 ,
D09791 		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
215ARICEPT1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬4件: 6, 13, 78, 124
216Aricept 10 mg1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
217Aricept 10 mg filmdragerade tabletter1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
218Aricept 5 mg1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
219Aricept 5 mg filmdragerade tabletter1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13
220Arm 1 - GEH120714 (18F) Injection----1件: 13
221Armodafinil1件: Armodafinil1件: D03215 1件: SLC6A3 💬7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬3件: 6, 13, 84
222ARN-6039----1件: 13
223Arzerra1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
224ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
225ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
226Arzerra®1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
227ASA----3件: 13, 97, 251
228ASB-683699----1件: 13
229Aspirin1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 46, 49, 51, 58, 64, 86, 113, 158, 210, 231
230Aspirin 650mg Oral Capsule1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
231ATA188----1件: 13
232Atacicept1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 13, 46, 49, 66
233Atacicept 150 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 49
234Atacicept 25 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 66
235Atacicept 75 mg1件: Atacicept1件: D09704 2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66
236ATG----4件: 13, 60, 96, 285
237ATL11021件: ATL1102---1件: 13
238Atomoxetine1件: Atomoxetine1件: D07473 1件: SLC6A2 💬1件: Synaptic vesicle cycle 💬4件: 6, 8, 13, 17
239Atorvastatin1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299
240ATX-MS-1467----1件: 13
241AUBAGIO1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
242AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
243AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
244Aubagio 14 mg film-coated tablets1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
245Aubagio®1件: Teriflunomide1件: D10172 1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13
246Autologous adipose derived mesenchymal cells----1件: 13
247Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved----1件: 13
248Autologous Bone Marrow-Derived Mononuclear Stem Cells----1件: 13
249Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----1件: 13
250Autologous Hematopoietic Stem Cell----1件: 13
251Autologous Hematopoietic Stem Cell Transplantation----3件: 13, 49, 84
252Autologous hematopoietic stem cells----1件: 13
253Autologous Mesenchymal Cell Product----1件: 13
254Autologous mesenchymal stem cell transplantation----1件: 13
255Autologous mesenchymal stem cells----5件: 2, 6, 13, 17, 46
256Autologous Stem Cells----2件: 13, 51
257AUTOLOGOUS T-LYMPHOCYTES----1件: 13
258Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)1件: Myelin basic protein---1件: 13
259AV605----1件: 13
260AVONEX1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97
261Avonex (Interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
262Avonex (interferon beta-1a), Biogen Idec Ltd2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
263AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
264Avonex 30 microgram/0.5 ml Solution for Injection1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
265AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
266Avonex 30 microgramos/0.5 ml Solución para inyección1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
267AVONEX 30 µg/0,5 ml solution for injection1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
268Avonex and Topamax1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
269AVONEX IM 4SIR 30MCG/0,5ML 4AG1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
270AVONEX*IM 4SIR 30MCG/0,5ML+4AG1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
271Avonex/Betaseron/Copaxone/Rebif3件: Glatiramer,
Interferon beta-1a,
Interferon beta-1b		2件: D00746 ,
D04554 		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
272Avonex/Zocor1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
273AVONEX®1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
274Avonex® monotherapy (6.0 MIU administered i.m. each week)1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
275AVP-923----3件: 2, 6, 13
276Azathioprine1件: Azathioprine1件: D00238 --21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162
277Azathioprine (AZA)1件: Azathioprine1件: D00238 --3件: 13, 19, 97
278Azatioprina1件: Azathioprine1件: D00238 --3件: 13, 96, 97
279AZATIOPRINA HEX. 50CPR 50MG BL1件: Azathioprine1件: D00238 --1件: 13
280Azithromycin1件: Azithromycin2件: D06390 ,
D07486 		--6件: 13, 84, 85, 96, 228, 299
281B001 injection----1件: 13
282Bacille Calmette-Guerin vaccine----1件: 13
283Bacille of Calmette-Guerin----1件: 13
284Baclofen1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206
285Baclofen 20 mg1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
286Baclofen ER Capsules (GRS) 10 mg1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
287Baclofen ER Capsules (GRS) 20 mg1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
288Baclofen ER Capsules (GRS) 30mg1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
289Baclofen ER Capsules (GRS) 40mg1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
290Baclofen ER Capsules (GRS) 50 mg1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
291Baclofen IR1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
292Baclofen Tablets USP1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
293Baclofen Tablets USP 10 mg1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13
294BAF312----2件: 13, 50
295BAF312 0,25 mg tablet----1件: 13
296BAF312 1 mg tablet----2件: 13, 50
297BAF312 4 mg tablet----1件: 13
298BAF312 hemifumarate----2件: 13, 50
299BAF312A----1件: 13
300Bafiertam1件: Monomethyl fumarate1件: D11492 --1件: 13
301Baminercept1件: Baminercept1件: D08866 1件: LTB 💬3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 13, 46, 53, 97
302Baseline disease modifying therapies (DMTs)----1件: 13
303Baseline Treatment----1件: 13
304BAT4406F----1件: 13
305BAY 79-4998----1件: 13
306BAY86-5046----1件: 13
307BAY86-5046_Interferon-beta-1b----1件: 13
308Bazedoxifene1件: Bazedoxifene---1件: 13
309Bazedoxifene Acetate2件: Acetate,
Bazedoxifene		---1件: 13
310BBR 2778----2件: 11, 13
311BCD-033 (interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
312BCD-054 180 mcg----1件: 13
313BCD-054 240 mcg----1件: 13
314BCD-063----1件: 13
315BCD-132----1件: 13
316BCD-132, 125 mg----1件: 13
317BCD-132, 500 mg----1件: 13
318BCG20-0134----1件: 13
319BEAM Regimen----1件: 13
320Beetainterferoni -1a----1件: 13
321BELIMUMAB1件: Belimumab1件: D03068 1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300
322Best Available Therapy (BAT)----1件: 13
323Beta-1b interferoni----1件: 13
324Beta-Alanine2件: Alanine,
beta-Alanine		2件: D00012 ,
D07561 		--1件: 13
325Beta-alanine supplementation2件: Alanine,
beta-Alanine		2件: D00012 ,
D07561 		--1件: 13
326Beta-Carotene1件: Beta carotene1件: D03101 --1件: 13
327Beta-Interferon----1件: 13
328BETACAROTENE1件: Beta carotene1件: D03101 --1件: 13
329BETAFERON1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
330BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
331BETAFERON 250 mcg1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
332Betaferon 250 microgram/ml1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
333Betaferon 250 microgram/ml, powder and solvent for solution for injection1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
334Betaferon 250 microgram/mL, powder and solvent for solution for injection.1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
335Betaferon 250 microgramos----1件: 13
336Betaferon 250mcg----1件: 13
337Betaferon 250µg1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
338BETAFERON 500 mcg1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
339Betaferon 500 µg----1件: 13
340Betaferon 500mcg----1件: 13
341Betaferon 500µg1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
342BETAFERON SC 15F 0,25MG 15SIR1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
343BETAFERON*15CONFEZ 0,25MG/ML+1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
344Betaferon/Betaseron----1件: 13
345Betaferon®1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
346BETAFERON® (interferon beta-1b)2件: Human interferon beta,
Interferon beta-1b		1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
347Betaseron1件: Interferon beta-1b1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
348Betaseron (Interferon beta-1b, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
349Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG2件: Human interferon beta,
Interferon beta-1b		1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
350Bevacizumab1件: Bevacizumab1件: D06409 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬6件: 13, 34, 85, 87, 227, 280
351Bexarotene1件: Bexarotene1件: D03106 3件: RXRA,
RXRB,
RXRG 💬		17件: Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬2件: 13, 75
352Bexsero1件: Neisseria meningitidis serogroup b nhba fusion protein antigen---6件: 11, 13, 61, 62, 66, 222
353BG-12 120----1件: 13
354BG00002----1件: 13
355BG00002 (natalizumab)1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
356BG00002-E (natalizumab high titer)1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
357BG00012----2件: 13, 46
358BG00012 (DMF)----1件: 13
359BG00012 (DMF) (Tecfidera®.)----1件: 13
360BG0002 (natalizumab)1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
361BG9418 (interferon beta 1-a)2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
362BG9418 (interferon beta-1a)2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97
363BGC20-0134----1件: 13
364BGG492----1件: 13
365BHT----1件: 13
366BHT-3009----1件: 13
367BHT-3009 0.5 mg----1件: 13
368BHT-3009 1.5 mg----1件: 13
369BHT-3009-01----1件: 13
370BIIB 017----1件: 13
371BIIB017----1件: 13
372BIIB017 (Peginterferon beta-1a)1件: Peginterferon beta-1a1件: D10483 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
373BIIB019----1件: 13
374BIIB019 (Daclizumab High Yield Process)1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
375BIIB019 (Daclizumab)1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
376BIIB033----1件: 13
377BIIB033 (ANTI-LINGO)----1件: 13
378BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957----1件: 13
379BIIB033 (opicinumab)1件: Opicinumab1件: D11767 1件: LINGO1 💬-1件: 13
380BIIB041----1件: 13
381BIIB041 (fampridine)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
382BIIB041 (Fampridine-SR)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
383BIIB041 (PR Fampridine)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
384BIIB061----1件: 13
385BIIB133----1件: 13
386Biobanking with genetic analysis----3件: 13, 51, 56
387Biological samples----1件: 13
388BIOTIN1件: Biotin1件: D00029 --5件: 2, 8, 10, 13, 20
389Biotina1件: Biotin1件: D00029 --2件: 8, 13
390BIRT 2584 XX----1件: 13
391BIRT 2584XX----1件: 13
392Bisacodyl1件: Bisacodyl1件: D00245 --1件: 13
393Blood sample----20件: 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299
394Blood samples----9件: 13, 41, 51, 61, 97, 227, 240, 271, 280
395Blood sampling----5件: 13, 46, 49, 51, 96
396BMMNC----1件: 13
397BMS 188667 (Abatacept)1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 13
398BNT162b2----7件: 13, 35, 46, 49, 50, 51, 107
399BNT162b2, Bivalent----7件: 13, 35, 46, 49, 50, 51, 107
400Bone marrow autologous mesenchymal stem cells transplantation----1件: 13
401BORAGE OIL1件: Borage oil---1件: 13
402BORAGE OIL 20% GLA1件: Borage oil---1件: 13
403BORTEZOMIB1件: Bortezomib1件: D03150 1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331
404BOSWELAN----1件: 13
405Boswellia Serrata1件: Indian frankincense---1件: 13
406Boswellia Serrata Extract1件: Indian frankincense---1件: 13
407Boswellia serrata extract PS0201Bo capsules1件: Indian frankincense---1件: 13
408Boswellic acids (BOSWELAN)----1件: 13
409Botox1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 2, 6, 13, 47, 51, 149, 226
410Botox 100 UNT Injection1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13
411BOTOX®1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13
412Botulinum Toxin----3件: 6, 13, 149
413Botulinum toxin A1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 13, 51, 149, 226
414BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13
415BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149
416Botulinum Toxin Type A 200U1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13
417Botulinum Toxin Type A 300U1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13
418Brimonidine1件: Brimonidine1件: D07540 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90
419Brimonidine tartrate1件: Brimonidine1件: D07540 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90
420BX-1----1件: 13
421C1-esterase inhibitor (Cinryze)1件: Human C1-esterase inhibitor---1件: 13
422C105----1件: 13
423Calcio1件: Calcium---4件: 13, 96, 97, 274
424CALCIO FOLINATO DC.IT1件: Calcium---1件: 13
425Calcium1件: Calcium---27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299
426Calcium and Vitamin D combination2件: Calcium,
Vitamin D		---1件: 13
427Calcium carbonate3件: Calcium,
Calcium carbonate,
Carbonate ion		2件: D00932 ,
D10802 		--8件: 13, 19, 46, 53, 75, 96, 235, 299
428Calcium levofolinate1件: Calcium---1件: 13
429Cannabidiol1件: Cannabidiol1件: D10915 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬18件: 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271
430Cannabidiol (CBD)1件: Cannabidiol1件: D10915 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬7件: 6, 13, 140, 144, 145, 156, 158
431Cannabidiol / Dronabinol capsule 5 mg+2,5 mg2件: Cannabidiol,
Dronabinol		2件: D00306 ,
D10915 		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13
432Cannabidiol Botanical Drug Substance (CBD BDS)1件: Cannabidiol1件: D10915 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13
433Cannabidiol capsule 5 mg1件: Cannabidiol1件: D10915 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13
434Cannabis1件: Medical Cannabis---7件: 2, 6, 13, 19, 90, 96, 97
435Cannabis Based Medicine Extract (Sativex)1件: Medical Cannabis---1件: 13
436Cannabis, Medical1件: Medical Cannabis---5件: 2, 6, 13, 96, 97
437Cannador----1件: 13
438Caprylic Triglyceride1件: Tricaprylin---1件: 13
439Capsules with 160 mg Teavigo (at least 94% EGCG)1件: Epigallocatechin gallate---1件: 13
440Carbamazepine1件: Carbamazepine1件: D00252 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 6, 13, 231
441CARBIDOPA1件: Carbidopa1件: D00558 1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 6, 13, 17, 90, 140, 164, 201
442Carbonate1件: Carbonate ion---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299
443CARBONE VEGETALE----1件: 13
444Carbone vegetale polvere----1件: 13
445Carmustine1件: Carmustine1件: D00254 --5件: 11, 13, 14, 28, 60
446Carmustine, etoposide, cytarabine, and melphalan (BEAM)4件: Carmustine,
Cytarabine,
Etoposide,
Melphalan		4件: D00125 ,
D00168 ,
D00254 ,
D00369 		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13
447Carnitine1件: Levocarnitine1件: D02176 --9件: 5, 13, 58, 86, 96, 97, 265, 298, 316
448Carnosine1件: Carnosine---2件: 6, 13
449Carnosine, capsulle, 2 g/day, 8 weeks1件: Carnosine---1件: 13
450CBD----13件: 2, 6, 8, 13, 36, 46, 51, 140, 144, 145, 156, 158, 206
451CCI-779----2件: 13, 46
452CD----8件: 6, 13, 46, 51, 63, 96, 97, 265
453CDP3231件: CDP323---1件: 13
454CELLCEPT----5件: 11, 13, 42, 43, 49
455Cellular therapy with EBV specific autologous CTL infusion----1件: 13
456Ceralifimod1件: Ceralifimod---1件: 13
457Ceralifmod----1件: 13
458Cerebro-spinal fluid----1件: 13
459Cesamet™ (nabilone)1件: Nabilone1件: D05099 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13
460Ceterizine----1件: 13
461Cetirizina1件: Cetirizine1件: D07662 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬3件: 13, 28, 300
462Cetirizina Mylan Generics1件: Cetirizine1件: D07662 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
463Cetirizine1件: Cetirizine1件: D07662 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 35
464CETIRIZINE HYDROCHLORIDE1件: Cetirizine1件: D07662 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
465CGP 77116----1件: 13
466Charcoal----1件: 13
467Chloride1件: Chloride ion---28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
468CHOLECALCIFEROL1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 13, 19, 34, 46, 49, 96, 97, 298, 299
469Cholecalciferol (Vitamin D3)1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 13, 299
470Cholecalciferol, Vitamin D31件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13
471Cholestyramine1件: Cholestyramine---2件: 13, 79
472CHR-1103 / GBR500----1件: 13
473Cianocobalamina1件: Cyanocobalamin4件: D00166 ,
D03615 ,
D03616 ,
D03617 		--1件: 13
474CIANOCOBALAMINA FU DC.IT1件: Cyanocobalamin4件: D00166 ,
D03615 ,
D03616 ,
D03617 		--1件: 13
475Ciclofosfamide1件: Cyclophosphamide2件: D00287 ,
D07760 		--1件: 13
476Cinryze1件: Human C1-esterase inhibitor---2件: 13, 61
477Circadin1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 13, 90
478Circadin ( INN= Melatonin)1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13
479CISAPRIDE1件: Cisapride2件: D00274 ,
D02092 		3件: HTR2A,
HTR3A,
HTR4 💬		7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 13
480Citalopram1件: Citalopram1件: D07704 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127
481CITOCHINE ED IMMUNOMODULATORI----1件: 13
482CLADRIBINA1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
483Cladribina oral1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
484CLADRIBINE1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 11, 13, 94
485Cladribine (MAVENCLAD®)1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
486Cladribine 3.5 mg/kg1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
487Cladribine 5.25 mg/kg1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
488Cladribine Oral Tablet1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
489Cladribine Pill1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
490Cladribine Tablet1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
491Cladribine Tablets1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
492Clemastine1件: Clemastine1件: D03535 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
493CLEMASTINE FUMARATE1件: Clemastine1件: D03535 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
494Clemastine Milstein 1 mg, tabletten1件: Clemastine1件: D03535 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
495Clostridium botulinum1件: Clostridium botulinum---1件: 13
496CLOSTRIDIUM BOTULINUM TOXIN TYPE A2件: Botulinum toxin type A,
Clostridium botulinum		1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13
497CNM-Au8----2件: 2, 13
498Cnp-MS-0601----1件: 13
499CNTO 1275----2件: 13, 96
500CO----3件: 13, 53, 85
501CO-14----1件: 13
502Coconut1件: Coconut---1件: 13
503Coconut oil2件: Coconut,
Coconut oil		1件: D05326 --1件: 13
504Coconut oil and epigallocatechin gallate4件: Coconut,
Coconut oil,
Epigallocatechin,
Epigallocatechin gallate		1件: D05326 --1件: 13
505COLECALCIFEROL1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬4件: 13, 46, 96, 228
506COLECALCIFEROL CONCENTRATE (OILY FORM)1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13
507COLESTIRAMINA1件: Cholestyramine---1件: 13
508Combination Product: ofatumumab with AI1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
509Combination Product: ofatumumab with PRF1件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
510Comirnaty1件: Tozinameran1件: D11971 --5件: 13, 46, 51, 53, 299
511Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion1件: Tozinameran1件: D11971 --1件: 13
512Continue IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107
513Continue IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107
514Continue IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107
515Continued Ocrelizumab1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
516Control group----4件: 2, 13, 46, 70
517COP----1件: 13
518COP-11件: Glatiramer---1件: 13
519COP-1/Copolymer-11件: Glatiramer---1件: 13
520COPAXONE1件: Glatiramer---1件: 13
521COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE1件: Glatiramer---1件: 13
522COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE1件: Glatiramer---1件: 13
523COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN1件: Glatiramer---1件: 13
524COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO1件: Glatiramer---1件: 13
525Copaxone 20 mg1件: Glatiramer---1件: 13
526Copaxone 20 mg/ml1件: Glatiramer---1件: 13
527COPAXONE 20 mg/ml solución inyectable en jeringa precargada1件: Glatiramer---1件: 13
528Copaxone 20 mg/ml solución para inyección en jeringa precargada1件: Glatiramer---1件: 13
529Copaxone 20 mg/ml Solution for Injection, pre-filled syringe1件: Glatiramer---1件: 13
530Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes1件: Glatiramer---1件: 13
531Copaxone 20mg/ml Solution for Injection, pre-filled syringe1件: Glatiramer---1件: 13
532Copaxone 40 mg/ml1件: Glatiramer---1件: 13
533Copaxone 40 mg/ml solution for injection, pre-filled syringe1件: Glatiramer---1件: 13
534Copaxone subcutaneous injection syringe1件: Glatiramer---1件: 13
535COPAXONE*SC 28SIR 20MG/ML1件: Glatiramer---1件: 13
536Copaxone-Teva1件: Glatiramer---1件: 13
537Copaxone®1件: Glatiramer---1件: 13
538Copolymer 1----1件: 13
539Copolymer-11件: Glatiramer---1件: 13
540Corticosteroid----9件: 13, 42, 43, 44, 45, 66, 96, 97, 222
541Corticosteroids & tanCART19/20----1件: 13
542Corticotropin1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 2, 13, 46, 75, 81, 84, 222
543COVID-19 mRNA Vaccine (nucleoside modified)----3件: 13, 46, 51
544COVID-19 mRNA vaccine (nucleoside-modified)----4件: 13, 46, 51, 299
545COVID-19 mRNA vaccine Moderna (CX-024414)----4件: 13, 46, 51, 299
546COVID-19 vaccination----1件: 13
547COVID19 vaccine----1件: 13
548Cranberry1件: Cranberry---1件: 13
549CRM1971件: Corynebacterium diphtheriae CRM197 protein---3件: 11, 13, 46
550CS-0777 tablets----1件: 13
551CSF sampling----1件: 13
552CT103A cells----2件: 11, 13
553Curcumin1件: Curcumin---10件: 2, 13, 46, 67, 74, 94, 96, 97, 139, 299
554Cyclophosfamide----1件: 13
555Cyclophosphamide1件: Cyclophosphamide2件: D00287 ,
D07760 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331
556Cyclophosphamide (drug)1件: Cyclophosphamide2件: D00287 ,
D07760 		--1件: 13
557Cyclophosphamide and ATG1件: Cyclophosphamide2件: D00287 ,
D07760 		--1件: 13
558Cyclophosphamide and fludarabine2件: Cyclophosphamide,
Fludarabine		3件: D00287 ,
D07760 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 11, 13
559CYCLOPHOSPHAMIDE MONOHYDRATE1件: Cyclophosphamide2件: D00287 ,
D07760 		--4件: 13, 60, 96, 256
560Cyclophosphamide/ATG1件: Cyclophosphamide2件: D00287 ,
D07760 		--1件: 13
561Cyclophosphamide/Glatiramer acetate3件: Acetate,
Cyclophosphamide,
Glatiramer		2件: D00287 ,
D07760 		--1件: 13
562Cyclophosphamide/Rituximab2件: Cyclophosphamide,
Rituximab		3件: D00287 ,
D02994 ,
D07760 		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
563CYMBALTA----3件: 6, 13, 49
564Cysteine1件: Cysteine---10件: 13, 19, 34, 84, 85, 88, 90, 254, 296, 310
565Cytarabine1件: Cytarabine1件: D00168 --7件: 11, 13, 14, 25, 49, 60, 65
566Cytolytic CD4+ T cells----1件: 13
567Cápsulas de Laquinimod 0.6 mg1件: Laquinimod---1件: 13
568Células madre mesenquimales----1件: 13
569D Mannose1件: Mannose---1件: 13
570D-aspartate----1件: 13
571D-BIOTIN1件: Biotin1件: D00029 --3件: 10, 13, 20
572D-BIOTINA1件: Biotin1件: D00029 --1件: 13
573DAC----1件: 13
574DAC HYP----1件: 13
575DAC-HYP----1件: 13
576DACLIZUMAB1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬8件: 13, 56, 60, 65, 97, 107, 283, 284
577Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
578Daclizumab High Yield Process1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
579DACLIZUMAB HYP1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
580Daclizumab HYP (DAC HYP1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
581Daclizumab HYP (DAC HYP)1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
582Daclizumab wih Greek suffix1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
583Daclizumab with Greek suufix1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
584Dalfampridine1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 4, 13
585Dalfampridine ER1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
586Dalfampridine ER, 10 Mg Oral Tablet, Extended Release1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
587Dalfampridine-ER 10mg1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
588Dalfampridine-ER 5mg1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
589Dantrolene1件: Dantrolene1件: D02347 --2件: 13, 233
590DAPIROLIZUMAB PEGOL1件: Dapirolizumab pegol---2件: 13, 49
591Daratumumab1件: Daratumumab1件: D10777 1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬5件: 13, 28, 48, 49, 63
592Darifenacin1件: Darifenacin1件: D03654 1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬2件: 6, 13
593Darifenacin (BAY79-4998)1件: Darifenacin1件: D03654 1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13
594DC-TAB----1件: 13
595Dekristol----2件: 13, 97
596Dekristol 20000 IE----1件: 13
597Dekristol® 400-Tabletten----1件: 13
598Dekristol®-Tablette 1 (400 IE)----1件: 13
599Delta-9-tetrahydrocannabinol1件: Dronabinol1件: D00306 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 8, 13, 36
600DEMESTRIL SEPTEM----1件: 13
601Desloratadine1件: Desloratadine1件: D03693 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
602Desloratadine given orally1件: Desloratadine1件: D03693 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
603Dexamethason----4件: 13, 28, 46, 331
604Dexamethasone1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
605Dexamethasone given orally1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
606Dexamethasone soduim phosphate2件: Dexamethasone,
Phosphate ion		1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
607Dexchlorpheniramine1件: Dexchlorpheniramine1件: D07803 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 49
608Dexrazoxane1件: Dexrazoxane1件: D03730 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13
609Dexrazoxane (DRZ) plus Mitoxantrone (MX)2件: Dexrazoxane,
Mitoxantrone		2件: D03730 ,
D08224 		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13
610Dextromethorphan1件: Dextromethorphan1件: D03742 6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
611DEXTROMETHORPHAN HYDROBROMIDE1件: Dextromethorphan1件: D03742 6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 13, 46
612Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: D03742 ,
D08458 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13
613Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: D03742 ,
D08458 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13
614Dextromethorphan/Quinidine2件: Dextromethorphan,
Quinidine		2件: D03742 ,
D08458 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 13
615Dextrometorfano1件: Dextromethorphan1件: D03742 6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13
616DEXTROMETORFANO HIDROBROMURO1件: Dextromethorphan1件: D03742 6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13
617Dextrometorfano/Quinidina2件: Dextromethorphan,
Quinidine		2件: D03742 ,
D08458 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 13
618Diazoxide1件: Diazoxide1件: D00294 2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬2件: 13, 193
619DIBASE----1件: 13
620Diclofenac1件: Diclofenac1件: D07816 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway